 James Goodrich
Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Polymerase II | 32 | 2026 | 351 | 4.610 |
Why?
| | Transcription, Genetic | 38 | 2026 | 1496 | 3.990 |
Why?
| | RNA, Untranslated | 14 | 2016 | 124 | 3.280 |
Why?
| | Promoter Regions, Genetic | 26 | 2024 | 1257 | 2.040 |
Why?
| | DNA | 19 | 2023 | 1463 | 1.380 |
Why?
| | Proto-Oncogene Proteins c-jun | 4 | 2014 | 55 | 1.020 |
Why?
| | Gene Expression Regulation | 10 | 2020 | 2608 | 0.980 |
Why?
| | Interleukin-2 | 5 | 2014 | 437 | 0.950 |
Why?
| | Short Interspersed Nucleotide Elements | 4 | 2010 | 12 | 0.950 |
Why?
| | RNA, Messenger | 12 | 2024 | 2832 | 0.890 |
Why?
| | Nucleic Acid Conformation | 14 | 2020 | 726 | 0.860 |
Why?
| | Heat-Shock Response | 5 | 2026 | 78 | 0.860 |
Why?
| | Alu Elements | 4 | 2014 | 29 | 0.830 |
Why?
| | Transcription Factors, TFII | 7 | 2025 | 44 | 0.800 |
Why?
| | TATA Box | 5 | 2017 | 22 | 0.770 |
Why?
| | TATA-Box Binding Protein | 5 | 2013 | 21 | 0.760 |
Why?
| | Single Molecule Imaging | 4 | 2025 | 46 | 0.700 |
Why?
| | NFATC Transcription Factors | 2 | 2013 | 93 | 0.690 |
Why?
| | Protein Binding | 18 | 2025 | 2273 | 0.680 |
Why?
| | Response Elements | 2 | 2023 | 89 | 0.680 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2023 | 529 | 0.640 |
Why?
| | RNA | 8 | 2023 | 940 | 0.630 |
Why?
| | Transcriptional Activation | 4 | 2013 | 383 | 0.610 |
Why?
| | Transcription Factor TFIIB | 4 | 2020 | 13 | 0.590 |
Why?
| | Herpesvirus 1, Human | 2 | 2021 | 84 | 0.590 |
Why?
| | TATA-Binding Protein Associated Factors | 3 | 2010 | 22 | 0.580 |
Why?
| | Transcription Initiation, Genetic | 2 | 2025 | 20 | 0.540 |
Why?
| | DNA-Binding Proteins | 5 | 2023 | 1499 | 0.530 |
Why?
| | Transcription Initiation Site | 2 | 2017 | 43 | 0.520 |
Why?
| | Base Sequence | 10 | 2017 | 2190 | 0.500 |
Why?
| | Transcription Factors, General | 1 | 2016 | 5 | 0.490 |
Why?
| | Microscopy, Fluorescence | 2 | 2025 | 416 | 0.480 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2015 | 87 | 0.430 |
Why?
| | Mammals | 1 | 2016 | 293 | 0.420 |
Why?
| | Transcription Factor TFIIH | 4 | 2025 | 40 | 0.410 |
Why?
| | Transcription Elongation, Genetic | 1 | 2013 | 24 | 0.380 |
Why?
| | Binding Sites | 7 | 2020 | 1329 | 0.380 |
Why?
| | Virus Replication | 1 | 2015 | 529 | 0.370 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 371 | 0.370 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2013 | 109 | 0.360 |
Why?
| | Chromatin | 7 | 2023 | 561 | 0.360 |
Why?
| | RNA Stability | 1 | 2013 | 119 | 0.350 |
Why?
| | Gene Silencing | 2 | 2010 | 205 | 0.350 |
Why?
| | Models, Genetic | 7 | 2018 | 536 | 0.340 |
Why?
| | Cell Cycle | 1 | 2014 | 596 | 0.330 |
Why?
| | RNA, Long Noncoding | 1 | 2013 | 177 | 0.320 |
Why?
| | Kinetics | 8 | 2020 | 1627 | 0.320 |
Why?
| | Models, Biological | 10 | 2013 | 1821 | 0.320 |
Why?
| | Proto-Oncogene Proteins c-fos | 4 | 2014 | 196 | 0.320 |
Why?
| | Genome | 2 | 2010 | 306 | 0.310 |
Why?
| | Protein Structure, Tertiary | 2 | 2010 | 862 | 0.310 |
Why?
| | Eukaryota | 1 | 2010 | 60 | 0.310 |
Why?
| | RNA Polymerase III | 1 | 2009 | 34 | 0.290 |
Why?
| | RNA, Small Nuclear | 1 | 2009 | 38 | 0.290 |
Why?
| | HMGB1 Protein | 2 | 2021 | 51 | 0.290 |
Why?
| | Transcription Factor TFIIA | 2 | 2010 | 7 | 0.280 |
Why?
| | Transcription Factor TFIID | 2 | 2010 | 21 | 0.280 |
Why?
| | Animals | 21 | 2020 | 38058 | 0.280 |
Why?
| | Humans | 43 | 2025 | 144759 | 0.280 |
Why?
| | Fluorescence Resonance Energy Transfer | 5 | 2016 | 178 | 0.280 |
Why?
| | Transcription Factors | 4 | 2024 | 1741 | 0.270 |
Why?
| | Molecular Sequence Data | 7 | 2013 | 2930 | 0.270 |
Why?
| | Cell Proliferation | 1 | 2014 | 2496 | 0.240 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 1 | 2026 | 28 | 0.240 |
Why?
| | Micrococcal Nuclease | 1 | 2006 | 26 | 0.240 |
Why?
| | Protein Interaction Mapping | 1 | 2006 | 104 | 0.230 |
Why?
| | Templates, Genetic | 4 | 2016 | 63 | 0.220 |
Why?
| | Nucleic Acids | 1 | 2006 | 72 | 0.220 |
Why?
| | Transcription Factor AP-1 | 3 | 2014 | 79 | 0.200 |
Why?
| | Trans-Activators | 1 | 2006 | 405 | 0.200 |
Why?
| | Catalytic Domain | 3 | 2013 | 232 | 0.200 |
Why?
| | Polynucleotides | 1 | 2023 | 14 | 0.200 |
Why?
| | Mice | 12 | 2020 | 18339 | 0.200 |
Why?
| | Transcription Termination, Genetic | 2 | 2026 | 23 | 0.200 |
Why?
| | Biochemistry | 1 | 2003 | 36 | 0.190 |
Why?
| | Saccharomyces cerevisiae | 2 | 2026 | 579 | 0.190 |
Why?
| | Oligoribonucleotides | 1 | 2002 | 52 | 0.180 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2026 | 419 | 0.180 |
Why?
| | HMGB2 Protein | 1 | 2021 | 4 | 0.180 |
Why?
| | Jurkat Cells | 2 | 2013 | 114 | 0.180 |
Why?
| | HMGB Proteins | 1 | 2021 | 17 | 0.180 |
Why?
| | Cell Line | 4 | 2023 | 2882 | 0.170 |
Why?
| | Immediate-Early Proteins | 1 | 2021 | 48 | 0.170 |
Why?
| | Chromatin Immunoprecipitation | 3 | 2018 | 139 | 0.170 |
Why?
| | Recombinant Proteins | 3 | 2010 | 1370 | 0.170 |
Why?
| | Tumor Suppressor Proteins | 1 | 2023 | 321 | 0.170 |
Why?
| | NIH 3T3 Cells | 4 | 2018 | 148 | 0.160 |
Why?
| | Herpes Simplex | 1 | 2021 | 98 | 0.160 |
Why?
| | Models, Molecular | 2 | 2020 | 1618 | 0.160 |
Why?
| | Aptamers, Nucleotide | 2 | 2014 | 85 | 0.150 |
Why?
| | Proteins | 1 | 2006 | 1021 | 0.150 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 116 | 0.150 |
Why?
| | HeLa Cells | 2 | 2013 | 650 | 0.150 |
Why?
| | Muscle Development | 1 | 2020 | 116 | 0.150 |
Why?
| | Ethanol | 1 | 2023 | 627 | 0.140 |
Why?
| | Phosphorylation | 4 | 2026 | 1732 | 0.140 |
Why?
| | Recombinant Fusion Proteins | 3 | 2006 | 675 | 0.140 |
Why?
| | RNA Interference | 1 | 2020 | 476 | 0.140 |
Why?
| | Nucleosomes | 3 | 2021 | 165 | 0.130 |
Why?
| | Consensus Sequence | 1 | 2017 | 74 | 0.130 |
Why?
| | Fluorescent Dyes | 2 | 2016 | 329 | 0.130 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2020 | 549 | 0.120 |
Why?
| | Enzyme Assays | 1 | 2016 | 25 | 0.120 |
Why?
| | Enzymes, Immobilized | 1 | 2016 | 30 | 0.120 |
Why?
| | DNA-Directed RNA Polymerases | 2 | 2009 | 63 | 0.120 |
Why?
| | Protein Stability | 1 | 2016 | 178 | 0.110 |
Why?
| | Protein Multimerization | 2 | 2014 | 213 | 0.110 |
Why?
| | Glutathione Transferase | 2 | 2006 | 100 | 0.110 |
Why?
| | Dimerization | 2 | 2006 | 194 | 0.110 |
Why?
| | Binding, Competitive | 1 | 2015 | 193 | 0.110 |
Why?
| | Thermodynamics | 2 | 2007 | 426 | 0.100 |
Why?
| | In Vitro Techniques | 3 | 2005 | 1047 | 0.100 |
Why?
| | Mutation | 3 | 2013 | 4089 | 0.100 |
Why?
| | MicroRNAs | 1 | 2020 | 701 | 0.100 |
Why?
| | DNA Cleavage | 1 | 2013 | 8 | 0.100 |
Why?
| | Plasmids | 2 | 2004 | 379 | 0.100 |
Why?
| | Luciferases | 1 | 2013 | 152 | 0.100 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 824 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2004 | 2027 | 0.090 |
Why?
| | Time Factors | 3 | 2009 | 7173 | 0.080 |
Why?
| | Transfection | 1 | 2013 | 940 | 0.080 |
Why?
| | Down-Regulation | 2 | 2010 | 627 | 0.080 |
Why?
| | Breast Neoplasms | 1 | 2023 | 2452 | 0.080 |
Why?
| | Yeasts | 1 | 2010 | 52 | 0.080 |
Why?
| | Oligonucleotides, Antisense | 2 | 2008 | 116 | 0.080 |
Why?
| | Germ Cells | 1 | 2010 | 66 | 0.080 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2010 | 148 | 0.080 |
Why?
| | Embryonic Development | 1 | 2010 | 125 | 0.070 |
Why?
| | Esterification | 1 | 2009 | 9 | 0.070 |
Why?
| | DNA Primers | 1 | 2010 | 512 | 0.070 |
Why?
| | Genomic Imprinting | 1 | 2009 | 26 | 0.070 |
Why?
| | Hot Temperature | 3 | 2011 | 407 | 0.070 |
Why?
| | Drosophila melanogaster | 1 | 2010 | 236 | 0.070 |
Why?
| | Cell Differentiation | 2 | 2020 | 2050 | 0.070 |
Why?
| | Protein Conformation | 2 | 2013 | 946 | 0.070 |
Why?
| | RNA, Bacterial | 1 | 2009 | 189 | 0.070 |
Why?
| | Gene Regulatory Networks | 1 | 2010 | 318 | 0.070 |
Why?
| | Sequence Analysis | 1 | 2007 | 35 | 0.060 |
Why?
| | Peptide Elongation Factor 1 | 1 | 2006 | 10 | 0.060 |
Why?
| | Heat Shock Transcription Factors | 1 | 2006 | 21 | 0.060 |
Why?
| | Centrifugation | 1 | 2006 | 27 | 0.060 |
Why?
| | Chromatography, Affinity | 1 | 2006 | 85 | 0.060 |
Why?
| | Sepharose | 1 | 2006 | 32 | 0.060 |
Why?
| | Enhancer Elements, Genetic | 1 | 2007 | 192 | 0.060 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 331 | 0.060 |
Why?
| | Protein Subunits | 1 | 2025 | 226 | 0.050 |
Why?
| | Adenoviridae | 1 | 2005 | 199 | 0.050 |
Why?
| | Leucine Zippers | 1 | 2004 | 17 | 0.050 |
Why?
| | Salts | 1 | 2004 | 37 | 0.050 |
Why?
| | Cell Nucleus | 2 | 2004 | 618 | 0.050 |
Why?
| | Glutathione | 1 | 2006 | 375 | 0.050 |
Why?
| | COS Cells | 1 | 2004 | 181 | 0.050 |
Why?
| | Histone Acetyltransferases | 1 | 2004 | 62 | 0.050 |
Why?
| | Amino Acid Sequence | 2 | 2004 | 2155 | 0.050 |
Why?
| | Breast | 1 | 2023 | 158 | 0.050 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2002 | 56 | 0.040 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1982 | 0.040 |
Why?
| | Models, Chemical | 1 | 2003 | 269 | 0.040 |
Why?
| | Peptides | 2 | 2004 | 995 | 0.040 |
Why?
| | RNA, Transfer | 1 | 2002 | 144 | 0.040 |
Why?
| | Histone Deacetylases | 1 | 2002 | 210 | 0.040 |
Why?
| | Fluorescence | 1 | 2020 | 161 | 0.040 |
Why?
| | Myoblasts | 1 | 2020 | 84 | 0.040 |
Why?
| | 3' Untranslated Regions | 1 | 2020 | 152 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2023 | 462 | 0.040 |
Why?
| | Genome, Human | 1 | 2021 | 422 | 0.040 |
Why?
| | DNA Footprinting | 2 | 2010 | 33 | 0.040 |
Why?
| | Cleavage And Polyadenylation Specificity Factor | 1 | 2018 | 10 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 744 | 0.040 |
Why?
| | Repressor Proteins | 1 | 2002 | 437 | 0.040 |
Why?
| | Optical Imaging | 1 | 2019 | 64 | 0.040 |
Why?
| | CRISPR-Cas Systems | 1 | 2020 | 170 | 0.030 |
Why?
| | Homeostasis | 1 | 2021 | 640 | 0.030 |
Why?
| | Protein Domains | 1 | 2016 | 313 | 0.030 |
Why?
| | SELEX Aptamer Technique | 1 | 2014 | 16 | 0.030 |
Why?
| | Optical Tweezers | 1 | 2014 | 21 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2014 | 275 | 0.020 |
Why?
| | Epigenetic Repression | 1 | 2013 | 4 | 0.020 |
Why?
| | Buffers | 1 | 2013 | 55 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2013 | 510 | 0.020 |
Why?
| | Cyclin H | 1 | 2011 | 2 | 0.020 |
Why?
| | Serine | 1 | 2011 | 145 | 0.020 |
Why?
| | Isomerism | 1 | 2010 | 57 | 0.020 |
Why?
| | Deoxyribonuclease I | 1 | 2010 | 41 | 0.020 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2011 | 123 | 0.020 |
Why?
| | Female | 2 | 2023 | 78271 | 0.020 |
Why?
| | Protein Kinases | 1 | 2011 | 315 | 0.020 |
Why?
| | Actins | 1 | 2011 | 425 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 1187 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2007 | 193 | 0.020 |
Why?
| | Algorithms | 1 | 2013 | 1837 | 0.010 |
Why?
| | Precipitin Tests | 1 | 2004 | 93 | 0.010 |
Why?
| | Male | 1 | 2010 | 72315 | 0.010 |
Why?
| | Okadaic Acid | 1 | 2002 | 15 | 0.010 |
Why?
| | Nocodazole | 1 | 2002 | 17 | 0.010 |
Why?
| | Histone Deacetylase 2 | 1 | 2002 | 10 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 983 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 2002 | 74 | 0.010 |
Why?
| | K562 Cells | 1 | 2002 | 93 | 0.010 |
Why?
| | Catalysis | 1 | 2002 | 322 | 0.010 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2002 | 177 | 0.010 |
Why?
| | Paclitaxel | 1 | 2002 | 255 | 0.010 |
Why?
| | Mitosis | 1 | 2002 | 200 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2002 | 824 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2002 | 1716 | 0.010 |
Why?
| | Histones | 1 | 2002 | 669 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2002 | 2194 | 0.010 |
Why?
| | Signal Transduction | 1 | 2002 | 5226 | 0.000 |
Why?
|
|
Goodrich's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|